Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
CSPCY
12.98%
▼ -47.51%
BIOVF
27.00%
▲ 15.89%
Gross Margin
CSPCY
76.15%
▲ 10.59%
BIOVF
76.68%
▲ 0.98%
Free Cash Flow
CSPCY
$0.00
▼ -$280.77M
BIOVF
$167.88M
▲ $72.37M
Net Debt / EBITDA
CSPCY
-1.15
▼ -0.47
BIOVF
1.30
▼ -0.27
Operating Margin
CSPCY
39.51%
▲ 28.50%
BIOVF
26.41%
▲ 0.40%
P/E Ratio
CSPCY
15.32
▼ -0.04
BIOVF
171.97
▼ -91.76